Incidence of Venous Thromboembolism After Elective Isolated Lumbar Decompression: A Systematic Review and Meta-Analysis.

Publication/Presentation Date

11-13-2026

Abstract

STUDY DESIGN: Systematic review and meta-analysis.

OBJECTIVE: To determine the reported incidence of deep vein thrombosis (DVT), pulmonary embolism (PE), and composite venous thromboembolism (VTE) after isolated lumbar decompression.

SUMMARY OF BACKGROUND DATA: Prior VTE estimates often combine decompression-only procedures with more complex spine surgery, limiting procedure-specific risk estimation.

METHODS: MEDLINE, Embase, and CENTRAL were searched on March 2, 2026, with surveillance through June 17, 2026. Decompression-only cohorts without fusion or instrumentation were eligible. Clinically detected, coded, or patient-reported outcomes were analyzed separately by event type and follow-up using random-effects binomial-normal generalized linear mixed models when at least five studies contributed data. Leave-one-out sensitivity analyses were performed.

RESULTS: Twenty-five studies had a combined reported sample size of 831,732 patients. At 30 days, pooled DVT incidence was 0.283% (9 studies; 235,490 patients; 95% CI, 0.203%-0.393%) and PE incidence was 0.273% (7 studies; 235,341 patients; 95% CI, 0.171%-0.437%). At 90 days, DVT incidence was 0.225% (7 studies; 163,074 patients; 95% CI, 0.056%-0.905%) and PE incidence was 0.183% (6 studies; 162,772 patients; 95% CI, 0.041%-0.825%). Composite VTE estimates were heterogeneous. The low 30-day DVT and PE estimates persisted in leave-one-out analyses, while 90-day estimates were more sensitive to study inclusion. Only three studies reported chemical prophylaxis regimens. Different cohorts contributed to the two windows, which should not be interpreted as a temporal trend.

CONCLUSION: Reported 30-day DVT and PE incidences after isolated lumbar decompression were each approximately three events per 1,000 patients. These estimates provide a procedure-specific benchmark for counseling but do not establish the risk without prophylaxis or the effectiveness and overall benefit of chemoprophylaxis.

ISSN

1528-1159

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

43043836

Department(s)

Administration and Leadership

Document Type

Article

Share

COinS